Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information visit www.azitrainc.com.
Location: United States, Connecticut, Branford
Employees: 11-50
Total raised: $37.9M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | Connecticu... | ctinnovati... |
| - | KdT Ventur... | kdtvc.com |
| - | Breakout L... | breakoutla... |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 15.03.2021 | - | $1M | - |
| 15.10.2020 | Series B | $17M | - |
| 22.10.2019 | Series A | $14M | - |
| 06.05.2018 | - | $2.15M | - |
| 05.04.2017 | Series A | $3.75M | - |
Mentions in press and media 19
| Date | Title | Description |
| 15.10.2020 | Leaps by Bayer Leads $17M Series B Financing in Azitra | LEVERKUSEN, Germany & BRANFORD, Conn.--(BUSINESS WIRE)--Leaps by Bayer, the impact investment arm of Bayer AG, today announced a USD 8 million financial investment in US-based clinical-stage medical dermatology biotech company Azitra In... |
| 22.10.2019 | Azitra brings in Series A to advance microbiome skin therapies | Azitra has four topical therapies in the pipeline to treat Netherton syndrome, cancer treatment-associated rashes, eczema and ichthyosis vulgaris. Netherton is a chronic, orphan disease caused by a LEKTI protein deficiency. LEKTI regulates ... |
| 15.10.2019 | Azitra Completes $14 Million Series A Financing | FARMINGTON, Conn.--(BUSINESS WIRE)--Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that it has closed a $14 million Series A financing. The financin... |
| 15.10.2019 | Azitra Pulls In $14M Series A Funding | FARMINGTON, CT, Azitra today announced that it has closed a $14 million Series A financing. >> Click here for more funding data on Azitra >> To export Azitra funding data to PDF and Excel, click here Azitra, a clinical-st... |
| 15.10.2019 | Azitra Raises $14M in Series A Financing | Azitra Inc., a Farmington, Conn.-based clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, closed a $14m Series A financing. The round, which brought total funding raised to date to $1... |
| 06.05.2018 | Azitra Raises $2.15M | FARMINGTON, Conn.--(BUSINESS WIRE)-Azitra Inc. announced that it has secured $2.15 million in convertible debt financing to support advancement of the company’s pipeline of dermatology and skin care products. The financing was led by new in... |
| 03.05.2018 | Term Sheet — Thursday, May 3 | TWO BANKRUPTCIES AND A WEDDING Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop SHUT OUT: In case you missed this, Birchbox is going through some stuff. Early investor Viking Global has... |
| 03.05.2018 | Azitra Secures $2.15M Convertible Debt | FARMINGTON, CT, Azitra announced that it has secured $2.15M in convertible debt financing to support advancement of the company's pipeline of dermatology and skin care products. >> Click here for more funding data on Azitra >&g... |
| 02.05.2018 | Azitra Secures $2.15M Convertible Debt Financing | Azitra Inc., a Famington, Conn.-based biotechnology company, secured $2.15m in convertible debt financing. The financing was led by new investor Connecticut Innovations, and existing investor Bios Partners. An additional new investor, KdT V... |
| 13.04.2017 | Breakout Labs backs antibacterials, genomics and biosensor tattoos | From California to Boston to NYC, four more startups have been accepted into the [Peter] Thiel Foundation’s Breakout Labs, a philanthropic incubator for seed-stage companies. Founded in 2012, Breakout Labs has now invested in some 34 compan... |
Show more